<DOC>
	<DOCNO>NCT01501331</DOCNO>
	<brief_summary>The Boston Scientific Energen family capable measure respiratory rate trend ( RRT ) daily basis transmission data via Remote Monitoring technology . This may result early detection imminent decompensation presymptomatic stage . The study assess respiratory trend correlation clinically relevant heart failure event .</brief_summary>
	<brief_title>Multiparametric Heart Failure Evaluation Internal Cardioverter Defibrillators ( ICD ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient eligible 1 , 2 3chamber ICD implantation accord current guideline patient already implant within past 45 day Energen device successor Able provide write inform consent Life expectancy &lt; 12 month Anticipated noncompliance followup scheme Moderate severe Chronic Obstructive Pulmonary Disease Primary pulmonary hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Internal Cardioverter Defibrillators</keyword>
</DOC>